Research programme: peptide therapeutics for pain - Johnson and Johnson Innovation/ University of QueenslandAlternative Names: Peptides derived from spider venom
Latest Information Update: 03 Nov 2014
At a glance
- Originator Johnson & Johnson Innovation; University of Queensland
- Class Peptides
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Pain